Brighton Jones LLC’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $3.11M | Buy |
+6,327
| New | +$3.43M | 0.07% | 198 |
|
|
2025
Q4 | – | Sell |
-5,063
| Closed | -$2.46M | – | 861 |
|
|
2025
Q3 | $2.46M | Buy |
5,063
+88
| +2% | +$41K | 0.06% | 187 |
|
|
2025
Q2 | $2.02M | Buy |
4,975
+285
| +6% | +$119K | 0.05% | 192 |
|
|
2025
Q1 | $2.33M | Buy |
4,690
+281
| +6% | +$152K | 0.07% | 153 |
|
|
2024
Q4 | $2.29M | Buy |
4,409
+988
| +29% | +$543K | 0.07% | 150 |
|
|
2024
Q3 | $2.12M | Sell |
3,421
-876
| -20% | -$519K | 0.08% | 132 |
|
|
2024
Q2 | $2.38M | Buy |
4,297
+240
| +6% | +$137K | 0.08% | 127 |
|
|
2024
Q1 | $2.36M | Buy |
4,057
+209
| +5% | +$117K | 0.09% | 125 |
|
|
2023
Q4 | $2.04M | Sell |
3,848
-146
| -4% | -$70.7K | 0.09% | 132 |
|
|
2023
Q3 | $2.02M | Buy |
3,994
+67
| +2% | +$35.7K | 0.1% | 112 |
|
|
2023
Q2 | $2.05M | Buy |
3,927
+336
| +9% | +$181K | 0.1% | 117 |
|
|
2023
Q1 | $2.07M | Buy |
3,591
+63
| +2% | +$35.5K | 0.12% | 107 |
|
|
2022
Q4 | $1.94M | Sell |
3,528
-70
| -2% | -$37.1K | 0.12% | 107 |
|
|
2022
Q3 | $1.82M | Buy |
3,598
+190
| +6% | +$106K | 0.11% | 106 |
|
|
2022
Q2 | $1.85M | Sell |
3,408
-17
| -0.5% | -$9.36K | 0.11% | 107 |
|
|
2022
Q1 | $2.02M | Buy |
3,425
+9
| +0.3% | +$5.17K | 0.09% | 107 |
|
|
2021
Q4 | $2.28M | Buy |
3,416
+65
| +2% | +$40.6K | 0.11% | 97 |
|
|
2021
Q3 | $1.91M | Buy |
3,351
+8
| +0.2% | +$4.39K | 0.1% | 95 |
|
|
2021
Q2 | $1.69M | Buy |
3,343
+261
| +8% | +$123K | 0.09% | 103 |
|
|
2021
Q1 | $1.41M | Sell |
3,082
-36
| -1% | -$17.2K | 0.08% | 111 |
|
|
2020
Q4 | $1.45M | Buy |
3,118
+270
| +9% | +$127K | 0.09% | 100 |
|
|
2020
Q3 | $1.26M | Buy |
2,848
+771
| +37% | +$319K | 0.09% | 96 |
|
|
2020
Q2 | $753K | Sell |
2,077
-255
| -11% | -$85.5K | 0.06% | 136 |
|
|
2020
Q1 | $661K | Buy |
2,332
+410
| +21% | +$129K | 0.07% | 131 |
|
|
2019
Q4 | $624K | Sell |
1,922
-363
| -16% | -$110K | 0.07% | 162 |
|
|
2019
Q3 | $665K | Sell |
2,285
-265
| -10% | -$75.9K | 0.08% | 139 |
|
|
2019
Q2 | $749K | Sell |
2,550
-79
| -3% | -$21.8K | 0.09% | 122 |
|
|
2019
Q1 | $720K | Buy |
2,629
+1,193
| +83% | +$297K | 0.09% | 128 |
|
|
2018
Q4 | $321K | Buy |
1,436
+117
| +9% | +$27.5K | 0.05% | 184 |
|
|
2018
Q3 | $322K | Hold |
1,319
| – | – | 0.04% | 195 |
|
|
2018
Q2 | $273K | Buy |
1,319
+52
| +4% | +$11K | 0.04% | 241 |
|
|
2018
Q1 | $262K | Sell |
1,267
-222
| -15% | -$46.6K | 0.04% | 235 |
|
|
2017
Q4 | $283K | Sell |
1,489
-122
| -8% | -$23.4K | 0.03% | 227 |
|
|
2017
Q3 | $305K | Buy |
1,611
+156
| +11% | +$28.3K | 0.04% | 207 |
|
|
2017
Q2 | $254K | Buy |
+1,455
| New | +$244K | 0.04% | 216 |
|
|
2015
Q1 | – | Sell |
-2,591
| Closed | -$325K | – | 200 |
|
|
2014
Q4 | $325K | Buy |
2,591
+3
| +0.1% | +$365 | 0.07% | 139 |
|
|
2014
Q3 | $315K | Sell |
2,588
-17
| -0.7% | -$2.07K | 0.07% | 144 |
|
|
2014
Q2 | $307K | Buy |
2,605
+31
| +1% | +$3.65K | 0.07% | 135 |
|
|
2014
Q1 | $310K | Buy |
2,574
+34
| +1% | +$4.04K | 0.07% | 131 |
|
|
2013
Q4 | $283K | Buy |
2,540
+30
| +1% | +$2.98K | 0.06% | 137 |
|
|
2013
Q3 | $231K | Buy |
+2,510
| New | +$227K | 0.06% | 140 |
|
Other funds holding TMO
VCM
Brighton Jones LLC's TMO Position: Q1 2026 in Review
Brighton Jones LLC opened a new position in Thermo Fisher Scientific (TMO) in Q1 2026: 6,327 shares worth $3.11M. The stake represents 0.07% of the portfolio and ranks #198 among its holdings. This is a return to the name: Brighton Jones LLC previously reported a position in TMO as recently as Q3 2025.
Brighton Jones LLC first reported a position in TMO in Q3 2013 and has held it in 41 quarters since. 2,594 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Brighton Jones LLC held 6,327 shares of Thermo Fisher Scientific worth $3.11M as of Q1 2026.
- Thermo Fisher Scientific was a new Brighton Jones LLC position in Q1 2026.
- Thermo Fisher Scientific made up 0.07% of Brighton Jones LLC's portfolio in Q1 2026, its #198 holding.
- Brighton Jones LLC first reported a position in Thermo Fisher Scientific in Q3 2013 and has held it in 41 quarters since.
- 2,594 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Brighton Jones LLC's 13F filing for Q1 2026, filed 28 Apr 2026.